Palatin Technologies Company
Palatin Technologies, a biopharmaceutical company, develops targeted receptor specific peptide therapeutics for the treatment of diseases.
.jpg)
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Industry:
Sexual Healthcare
Last Funding Date:
2016-12-08
Technology:
Cancer
Founded Date:
1986
Headquarters:
Cranbury, New Jersey, United States
Total Funding:
$104 000 000
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50